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Abstract
The study of the concentration of metalloproteinases, pro- and anti-inflammatory cytokines, lymphocyte activation markers 
in seminal plasma of men with oligosymptomatic forms of chronic inflammation of the urogenital tract (CIUT), depending on the 
fertility rate are presented in the article. 
Quantitative characteristics in male sperm with different forms of pathospermia were studied for matrix metalloproteinases 
(MMP)-2 and MMP-9 and their inhibitors – tissue inhibitors of metalloproteinases (TIMP)-1 and TIMP-2. It was shown, that during 
chronic inflammation of the urogenital tract of men are shifting levels of cytokine profile, reducing the concentration of metallo-
proteinase-2, chemokines – fractalkine and regulated by activation, expression and secretion of normal T-cells (RANTES), sharp 
increase in IL-8, MCP-1 and elevation of the CD25+/CD95+, indicating that the disturbance of apoptosis of pathological forms gen-
erative cells and their accumulation in the sperm. 
The ratio of immunological indices IL-2/IL-4, IL-10/IL-12 was calculated and a significant increase in the IL-10/IL-12 index 
was noted in the group of individuals with elevated levels of hypercapitated form of sperm, and a reduced proportion of this ratio 
was observed in the microsomatic morphology of sperm. Prolonged inflammation in the genital area accompanied by depletion of 
the local immune system, resulting in the development of infertility.
Immunocorrection therapy for men with CIUT should take into account the peculiarities of changes in local immunity 
and be differentiated depending on the prevalence of certain pathological forms of sperm and changes in the cytokine profile of 
the seminal plasma.
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1. Introduction
One of the main directions of modern scientific research is the study of proteolysis as a 
special form of biological regulation. Proteolysis is constantly occurring in living organisms and in 
the environment under the influence of microorganisms, resulting in a variety of biologically active 
substances – enzymes, hormones, peptides, amino acids, etc. Proteolytic enzymes that have high 
biological activity are involved into the functioning of various organs and systems of the body and 
in the regulation of biological processes. They not only carry out non-specific decomposition of 
protein molecules, but also control the functions and systems of the organism, which is realized in 
the reactions of general and limited proteolysis. According to modern notions, protease enzymes 
support the balance between death and cell degradation and their recovery, they participate in 
cellular mechanisms of proteasome degradation [1]. The proteolytic processes are necessary for 
the normal functioning of the organism. Violations of the mechanisms of biological regulation 
can cause serious diseases: arthritis, multiple sclerosis, cancerous tumors, and others. Proteolytic 
enzymes play an important role in metastasis in the passage of malignant cells through the mem-
brane, their migration and invasion into the extracellular matrix. In these processes, 4 classes of 
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proteolytic enzymes – matrix metalloproteinases, cysteine and serine proteinases, as well as pro-
tein kinase aspartate of cathepsin D – participate [2, 3]. Matrix metalloproteinases (MMP) – the 
family of extracellular zinc-containing proteinases. Today about 30 MMPs are known, their role 
in the processes of morphogenesis, apoptosis, remodeling and resorption of tissues continues to be 
studied [4, 5]. There are five types of MMP: collagenase (MMP-1, -8 and -13), glutathione (MMP-2 
and -9), stromelysin (MMP-3, -10, -11), elastase (MMP-7, -12) and the membrane type (MT-MMP, 
MMP-14, -15, -16 and -17) [6, 7].
MMPs are secreted as well as inflammatory and stromal cells in response to exogenous 
stimuli and proinflammatory cytokines: tumor necrosis factor (TNF)-α, interleukin (IL)-1β. Such 
cytokines, such as interferon (IFN)-γ, IL-4 and IL-10, decrease the secretion of MMP [8, 9]. 
The substrate for MMP-2 and MMP-9 is collagen I, IV, V, VII and X types, elastin, fi-
bronectin, IL-1β, IL-2, IL-8, IL-15, transforming growth factor (TGF)-β, chemokines, INF-β, sol-
uble forms of receptors for a number of interleukins, etc. The works of scientists has determined 
the effect of MMP-3, MMP-8, MMP-13, MMP-14, MMP-28 on the level of several chemokines: 
fractalkine, IL-8, regulated by activation, expression and secretion of normal T cells (RANTES) 
[10, 11]. Consequently, metalloproteinases are involved into the development of the inflammatory 
process [12, 13]. Protective functions for MMP-9 were revealed in the suppression of lymphopro-
liferation and dampening of systemic autoimmunity, cautioning against the long-term use of MMP 
inhibitors in autoimmune lymphoproliferative syndrome [14]. MMP2 and MMP9 lay a key role in 
regulating T-cell activation [15]. MMP activity is regulated by tissue inhibitors of metalloprotein-
ases (TIMP) [16, 17]. The role of MMP in the functioning of the male reproductive system and in 
the fertilizing ability of sperm [18] was investigated. The raised levels of MMP-2 and MMP-9 in 
the secretion of prostate and testicles in men with prostate hyperplasia were demonstrated [19]. 
Quantitative characteristics in male sperm with different forms of pathospermia were studied for 
MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 [20]. It is believed that TIMP-1 is 
specific for MMP-9, and TIMP-2 for MMP-2 [10]. It is clear that during the inflammatory process 
in the urogenital tract of men, the levels of cytokines and biological substances that regulate their 
functional activity undergo certain changes. In men with chronic urogenital infection, a significant 
increase in the concentration of a number of cytokines - IL-1β, IL-5, IL-6, IL-13, IL-15, IL-17, 
IL-23, INF-α , monocytic chemotactic factor (MCP) and to a lesser extent - IL-2, IL-10, IL-12, 
IL-18, TNF-α, INF-γ [21]. The elevated levels of these inflammatory mediators indicate the in-
volvement of immune factors to protect the male genital tract. These changes are more important 
in the development of complications, in particular, infertility. The study of the peculiarities of the 
interaction of cytokines and metalloproteinases during inflammation in male genitals, obviously, 
will have not only diagnostic and therapeutic value, but may also address the issue of increasing 
the fertilizing potential [11].
2. Aim of the research
The objective of this study was to investigate the pro- and antiinflammatory cytokines in 
the seminal plasma of men with chronic inflammation of the urogenital tract (CIUT), CD4+CD25+, 
CD4+HLA-DR4+ and CD4+CD95+ lymphocytes activation markers, MMP-2 metalloproteinase, 
MMP-9 and their inhibitors TIMP-1, TIMP-2 depending on fertility. 
3. Materials and methods
The research was conducted on the basis of the Department of Family Medicine and Outpa-
tient Clinical Care and the Research Laboratory of the National Medical Academy of Postgraduate 
Education named after P. Shupik from 2013 to 2016.
Under our supervision were 69 patients with olygosymptomatic forms of chronic inflam-
mation of the urogenital tract (CIUT) aged from 24 to 40 years. All subjects were divided into two 
groups: the first (35 people) – infertile men and the second (34 people) – fertile men. All patients 
were examined clinically, including examination and palpation of the penis, scrotum and prostate 
gland, and carefully collected anamnesis. All patients gave semen for analysis. The ejaculation 
should not occur within 4–5 days on the eve of the delivery. Semen analysis was performed half an 
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hour after ejaculation and in accordance with WHO guidelines. Considered the concentration of 
sperm, pH of semen, the content of leukocytes and their populations (granulocytes, macrophages, 
lymphocytes). Patients with leucospermia were not included in the study. To determine the mor-
phology staining for Papanicolaou was used.
The levels of the following cytokines in serum and seminal plasma were studied by im-
munoassay in laboratory equipment of Sanofi diagnostic Pasteur (France) using ProCon (Protein 
Contour, SPb) certified test systems in Ukraine: IL-1β, IL-2 , IL-4, IL-6, IL-10, FNP-α. The con-
centration of IFN-γ was studied using the Ukrainian-certified test systems of the diagnostic sys-
tems (RF – Nizhny Novgorod). IL-8 and MCP-1 cytokine levels were tested in serum of blood 
and serum from semen by an immuno-enzymatic method using the IFA-BEST test system of LLC 
Vector-Best, Saint-Petersburg, level RANTES (regulated by activation, expression and secretion 
of normal T cells) and fractalkine test systems of RayBiotech, Inc., USA. The concentrations of 
IL-12 and IL-18 cytokines in serum and seminal plasma were determined by immunoassay using 
the STAT-FAX-303 PLUS analyzer (USA) at a wavelength of 492 nm. To determine the level of 
lymphocytes that expressed on their surface receptors for functional activation of CD4+CD25+, 
CD4+CD95+, CD4 + HLA-DR4 + (TRAIL receptor 1) cells, was used an erythrocytic diagnos-
ticum with monoclonal antibodies produced by the MedBioProject (RF) – Moscow) The ratio of 
immunological indices IL-2/IL-4, IL-10/IL-12 and CD25+/CD95+ was calculated.
The levels of MMP-2, MMP-9, TIMP-1 and TIMP-2 were measured in serum from sperm 
by the immuno-enzymatic method using the Ameters int. (United Kingdom) Biotrak test system.
Control parameters of concentrations of all of the above-mentioned cytokines were obtained 
during the study of 24 fertile men without clinical signs of the disease, similar in composition ac-
cording to age.
Statistical analysis was performed on a personal computer using the MedStat program pack-
age [22]. At the same time criterion χ2 was used for checking the indicators for normal distribution. 
The median was calculated, 25 % quartile, 75 % quartile, confidence intervals. To compare the 
indicators, the criterion χ2, the two-sided critical region, was used. To analyze the presence and the 
strength of the relationship, the Kendal correlation coefficient τ was calculated.
4. Results
The study of levels of metalloproteinases MMP-2, MMP-9 and their inhibitors TIMP-1, 
TIMP-2 in serum of male sperm with CIUT showed that the level of MMP-2 was significant-
ly lowered compared to control values. However, the MMP-2 in the group of infertility men 
declined more significantly – the difference of 2.9, in the group of fertile men the multiplicity 
of the difference was 1.4. The levels of MMP-9, TIMP-1 and TIMP-2 did not differ from the 
normative (Table 1).
Table 1
Indicators of levels of metalloproteinases and their serum plasma inhibitors in men with CIUT (Me±m 
[95 % confidence interval])
Indexes Norm Infertile men Fertile men
ММР-2, ng/ml
1646.4±124.8 
[1351.2; 1967.4]
576.489.3±*** 
[351.3; 767.6]
1134.478.6±** 
[993.7; 1349.8]
ММР-9, ng/ml
47.49.7±
[21.2; 77.4]
44.98.5±
[29.1; 67.7]
45.57.9±
[31.8; 68.5]
ТІМР-1,ng/ml
23478.3675.4±
[21751.2; 24867.4]
27547.6704.7±
[25424.5; 28667.6]
24163.6694.1±
[21974.3; 2589.7]
ТІМР-2, ng/ml
4538.2358.5±
[3851.2; 5367.4]
4794.5289.9±
[4021.6; 5167.8]
4635.9311.5±
[3905.7; 5397.5]
Note: the reliability of the difference between the indicators of the group and the indicators taken at the norm at values P: * – <0,05, 
** – <0,01, *** – <0,001
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The results of the study of the cytokine profile indicate that in the examined patients with 
infertility there is a significant increase in the concentration of IL-8 in the seminal plasma (215.5± 
±7.8 pg/ml, p<0.01) and the monocytic chemotactic factor MCP (926.4±30.2 pg/ml, p<0.001), 
in the group of fertile men the levels of these cytokines also increased (85.5±5.7 pg/ml, p<0.01 
and 185.2±12.5 pg/ml, p<0.001, respectively), but the multiplicity of the difference was signifi-
cantly lower compared to infertile men (Table 2). So for IL-8, the multiplicity of difference 
in the group of infertility and in the group of fertile men was 6.0 and 2.4 respectively, for 
MCP – 11.2 and 2.2. 
Table 2
Immunological parameters of male sperm serum with CIUT (Me±m [95 % confidence interval])
Indexes Norm Infertile men Fertile men
IL-1β, pg/ml 54.6±0.8 
[51.2;67.4]
5.4±0.5 *** 
[5.1;6.3]
36.4±2.1** 
[31.3;39.8]
IL-2, pg/ml 86.5±1.7  
[63.4;89.5]
14.2±1.3*** 
[12.5;16.5]
47.7±5.1** 
[35.2;64.6]
IL-4, pg/ml 24.1±1.2 
[23.5;32.7]
24.1±0.5 
[23.1;25.6]
25.1±0.9 
[23.1;27.6]
IL-6, pg/ml 34,1±1,2 
[32,1;36,7]
32,2±1,4 
[30,2;35,7]
32,0±1,3 
[30,1;34,5]
IL-8, pg/ml 36,1±1,5 
[35,4;40,3]
215,5±7,8*** 
[197,0;237,7]
85,5±5,7** 
[69,4;107,5]
IL-10, pg/ml 36,3±1,3 
[32,2;39,4]
35,1±1,3 
[32,5;41,5]
35,6±1,5 
[32,4;40,1]
IL-12, pg/ml 13,6±1,4 
[11,8;15.8]
9.6±0.3* 
[8.3;10.2]
13.5±0.8 
[11.5;15.7]
IL-18, pg/ml 28.1±0.8 
[25.6;30.4]
21.0±0.6*** 
[16.8;22.5]
25.5±1.2* 
[22.6;27.1]
IL-2/ IL-4 3.5±0.3 
[2.9;5.1]
0.6±0.2*** 
[0.4;1.7]
1.9±0.3** 
[1.4;2.6]
IL-10/ IL-12 2.7±0.2 
[2.2;5.4]
3.7±0.32** 
[2.0;6.7]
2.6±0.27 
[2.1;4.1]
МСР, pg/ml 82.4±1.4 
[78.8;80.3]
926.4±30.2*** 
[845.1;969.6]
185.2±12.5*** 
[886.0;992.8]
TNF-α, pg/ml 12.9±0.5 
[11.2;15.9]
12.1±0.9 
[11.5;15.2]
11.9±1.0 
[11.0;14.7]
RANTES, pg/ml 40.5±2.2 
[37.6;43.5]
12.7±1.0*** 
[9.8;14.6]
45.8±2.3* 
[40.1;49.7]
Fractalkine, pg/ml 29.4±1.5 
[26.1;32.0]
16.3±1.3*** 
[12.9;18.4]
87.4±8.2*** 
[73.6;108.0]
INF-γ, pg/ml 5.3±0.2 
[5.0;5.7]
5.1±1.2 
[4.3;7.1]
5.0±0.8 
[3.5;7.3]
CD4+CD25+, % 10.7±1.5 
[9.3;14.4]
16.3±1.4** 
[12.5;19.6]
12.4±1.3 
[10.2;15.6]
CD4+CD95+, % 11.8±1.2 
[8.1;14.0]
17.9±1.3** 
[10.3;21.1]
24.2±1.5*** 
[20.1;28.6]
CD4+HLA-DR4+, % 1.2±0.2 
[0.9;1.4]
1.8±0.2* 
[1.4;1.9]
1.3±0.2 
[0.9;1.7]
CD25+/CD95+ 0.900.14±
[0.80;1.12]
0.970.12±* 
[0.96;1.22]
0.510.11±* 
[0.39;0.65]
Note: the reliability of the difference between the indicators of the group of infertility men and the rates taken for the norm at values 
P: * – <0,05; ** – <0,01; *** – <0,001
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At the same time, in infertile men observed a significant decrease in the serum plasma con-
centrations of IL-1β (5.4±0.5 pg/ml, p<0.01), IL-2 (14.2±1.3 pg/ml, p<0.01), IL-12 (9.6±0.3 pg/ml, 
p<0.01), IL-18 (21.0±0.6 pg/ml, p<0.01). In the group of fertile men, the abovementioned cytokines 
also decreased, but less importantly than in infertile men. The concentrations of TNF-α, IL-4, IL-6, 
IL-10, IFN-γ in the seminal plasma of both groups of men did not exceed the corresponding mean 
concentrations of healthy men. Moreover, the levels of concentration of all of the abovementioned 
cytokines in the peripheral blood of patients with CIUT varied within normal limits. Interestingly, 
the study of the IL-10/IL-12 ratio was quite interesting. The literature indicates that a decrease in 
the IL-10/IL-12 ratio is a key factor in suppressing the effectiveness of local immune defense in 
the lower sections of the urogenital tract, inhibition of cellular mediated immune response, and 
the development of immunosuppression [23, 24]. In our study, there were diverse shifts in this 
ratio of infertility men. A significant increase in the IL-10/IL-12 index was noted in the group of 
individuals with elevated levels of hypercapitated form of sperm, and a reduced proportion of this 
ratio was observed in the microsomatic morphology of sperm. The obtained data emphasize the 
importance of microenvironment in the process of maturation of gametes. In the group of infertile 
men, the concentration of RANTES was significantly lower than normal (12.7±1.0 pg/ml, p<0.05). 
And the multiplicity of the difference on average was 3.2 times. However, in part of the patients 
of the infertile group (14 people) the difference in frequency was 6.3 times (mean 6.4±0.8 pg/ml, 
p<0.001). Morphometry of the sperm in this group of patients showed hypercapitated morphotype 
of sperm (τ=–0,86, p=0,4). The level of fractakline in the serum of semen of infertile patients sig-
nificantly decreased (16.3±1.3 pg/ml, p<0.001). In the group of fertile men, the levels of RANTES 
and fractakline, on the contrary, increased (45.8±2.3 g/ml, p<0.05 and 87.4±8.2 pg/ml, p<0.001, 
respectively).
In patients with CIUT, which was complicated by infertility, there was a marked increase 
in CD4+CD25+ levels in sperm, both in relative and absolute values and was 16.3±1.4 %, p<0.01 
(10.7±1.5 % in the control group), (p<0.05), indicating an increased activity against infectious de-
fense. At the same time, the mean value of CD4+CD25+ in semen was not changed in fertile men. 
The level of lymphocytes in the sperm of the infertile men with CD4+CD95+ expression was 
elevated in compare to the control group in both relative and absolute values and was 17.9±1.3 %, 
p<0.01 (11.8±1.2 % in the control group). The frequency difference was 1.5 times. At the same 
time, some of the patients in this group (12 people), the level of CD4+CD95+ in the sperm, on the 
contrary, decreased with respect to control, and the average value for this part of the patients was 
9.0±1.1 %, (p<0.01), which was less than 1,3 times the adopted norm. Decreased immunocompetent 
cells ready to enter the process of apoptosis can lead to imbalances in the immune system. About 
the activation of anti-infective protection is the tendency to increase the absolute level of cells with 
expression of CD4+HLA-DR4+ in this group of patients. In view of the literature data [25], we 
calculated the ratio of CD25+/CD95+. The study showed that there is a positive correlation between 
the increased value of the proportion of CD25+/CD95+ and the presence of hypercapitated forms 
of sperm. At the same time, an increase in this index was observed in the group of infertile men. A 
significant decrease in the proportion of CD25+/CD95+ was observed in a group of infertile men, 
whose spermometry has established the predominance of normosomatic forms of sperm. The ob-
tained data, in our opinion, testify to the toxic effect of activated lymphocytes in the sperm against 
the suppression of the processes of apoptosis.
5. Discussion 
The results of our study showed that the development of such a complication in men, as in-
fertility on the background of chronic inflammation of the urogenital tract is accompanied not only 
by the shift of microenvironment, but also by pathomorphological changes in the generative cells. 
The literature notes that MMP-2 inactivates a number of chemokines – fractakline, RANTES and 
proinflammatory cytokines – IL-1β, TNF-β [26]. The IL-8 protein under the influence of MMP-9, 
on the other hand, leads to increased activity of this cytokine [11]. MMP-9 by inactivating INF-γ 
can lead to prolonged inflammation [7]. Inflammation is usually characterized by elevated levels 
of metalloproteinases [9], however, the male examination from CIUT indicates, on the contrary, 
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a decrease in MMP-2 levels and a normal level of MMP-9 in serum, along with lower concentra-
tions of proinflammatory cytokines IL-1β, IL-2, IL-12, IL-18, which may indicate an exhaustion of 
the local immune system, despite normal immunological parameters in systemic circulation. The 
altered parameters of the cytokine profile in the urogenital tract obviously adversely affect the pro-
cesses of maturation, which results in the prevalence of pathological forms of sperm in the group 
of infertile men. Thus, the determination of the lower concentration of MMP-2 in serum can be a 
negative predictor of the development of infertility.
6. Conclusions
1. During the chronic inflammation in the urogenital tract, men undergo changes in pro- and 
anti-inflammatory cytokine levels, decreased concentrations of MMP-2, chemokines-fractalkine 
and RANTES, a sharp increase in IL-8, MCP-1 and an increase in the CD25+/CD95+ index, indi-
cating on violation of the processes of apoptosis of pathological forms of the generative cells, which 
leads to their accumulation in the semen.
2. Long inflammatory process in the genital organs is accompanied by exhaustion of the 
local immune system, resulting in the development of infertility.
3. Immunocorrection therapy for men with CIUT should take into account the peculiarities 
of changes in local immunity and be differentiated depending on the prevalence of certain patho-
logical forms of sperm and changes in the cytokine profile of the seminal plasma.
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